Literature DB >> 24816452

Spinal cord regeneration.

Wise Young1.   

Abstract

Three theories of regeneration dominate neuroscience today, all purporting to explain why the adult central nervous system (CNS) cannot regenerate. One theory proposes that Nogo, a molecule expressed by myelin, prevents axonal growth. The second theory emphasizes the role of glial scars. The third theory proposes that chondroitin sulfate proteoglycans (CSPGs) prevent axon growth. Blockade of Nogo, CSPG, and their receptors indeed can stop axon growth in vitro and improve functional recovery in animal spinal cord injury (SCI) models. These therapies also increase sprouting of surviving axons and plasticity. However, many investigators have reported regenerating spinal tracts without eliminating Nogo, glial scar, or CSPG. For example, many motor and sensory axons grow spontaneously in contused spinal cords, crossing gliotic tissue and white matter surrounding the injury site. Sensory axons grow long distances in injured dorsal columns after peripheral nerve lesions. Cell transplants and treatments that increase cAMP and neurotrophins stimulate motor and sensory axons to cross glial scars and to grow long distances in white matter. Genetic studies deleting all members of the Nogo family and even the Nogo receptor do not always improve regeneration in mice. A recent study reported that suppressing the phosphatase and tensin homolog (PTEN) gene promotes prolific corticospinal tract regeneration. These findings cannot be explained by the current theories proposing that Nogo and glial scars prevent regeneration. Spinal axons clearly can and will grow through glial scars and Nogo-expressing tissue under some circumstances. The observation that deleting PTEN allows corticospinal tract regeneration indicates that the PTEN/AKT/mTOR pathway regulates axonal growth. Finally, many other factors stimulate spinal axonal growth, including conditioning lesions, cAMP, glycogen synthetase kinase inhibition, and neurotrophins. To explain these disparate regenerative phenomena, I propose that the spinal cord has evolved regenerative mechanisms that are normally suppressed by multiple extrinsic and intrinsic factors but can be activated by injury, mediated by the PTEN/AKT/mTOR, cAMP, and GSK3b pathways, to stimulate neural growth and proliferation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816452     DOI: 10.3727/096368914X678427

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  32 in total

1.  Impacts of phosphatase and tensin homology deleted on chromosome ten (PTEN)-inhibiting chitosan scaffold on growth and differentiation of neural stem cells.

Authors:  Yixiang Guan; Fu Yang; Qi Yao; Jinlong Shi; Gequan Wang; Zhikai Gu; Fei Zhou; Jianhong Shen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Scaffold Ranking and Positional Scanning Identify Novel Neurite Outgrowth Promoters with Nanomolar Potency.

Authors:  Hassan Al-Ali; Ginamarie Debevec; Radleigh G Santos; Richard A Houghten; Jennifer C Davis; Adel Nefzi; Vance P Lemmon; John L Bixby; Marc A Giulianotti
Journal:  ACS Med Chem Lett       Date:  2018-09-24       Impact factor: 4.345

3.  Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models.

Authors:  Jing Xu; Jian He; Huang He; Renjun Peng; Jian Xi
Journal:  Mol Neurobiol       Date:  2016-12-05       Impact factor: 5.590

4.  Long-term, dynamic synaptic reorganization after GABAergic precursor cell transplantation into adult mouse spinal cord.

Authors:  Ida J Llewellyn-Smith; Allan I Basbaum; João M Bráz
Journal:  J Comp Neurol       Date:  2017-11-13       Impact factor: 3.215

5.  Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair.

Authors:  Dmitry Tukmachev; Serhiy Forostyak; Zuzana Koci; Kristyna Zaviskova; Irena Vackova; Karel Vyborny; Ioanna Sandvig; Axel Sandvig; Christopher J Medberry; Stephen F Badylak; Eva Sykova; Sarka Kubinova
Journal:  Tissue Eng Part A       Date:  2016-02       Impact factor: 3.845

6.  Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.

Authors:  Hassan Al-Ali; Do-Hun Lee; Matt C Danzi; Houssam Nassif; Prson Gautam; Krister Wennerberg; Bill Zuercher; David H Drewry; Jae K Lee; Vance P Lemmon; John L Bixby
Journal:  ACS Chem Biol       Date:  2015-06-24       Impact factor: 5.100

7.  Neurotrophin-3 Enhances the Effectiveness of Cell Therapy in Chronic Spinal Cord Injuries.

Authors:  O V Stepanova; A D Voronova; A V Chadin; G A Fursa; E K Karsuntseva; M P Valikhov; A S Semkina; I V Reshetov; V P Chekhonin
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

8.  Exercise dependent increase in axon regeneration into peripheral nerve grafts by propriospinal but not sensory neurons after spinal cord injury is associated with modulation of regeneration-associated genes.

Authors:  Rahul Sachdeva; Catherine C Theisen; Vinu Ninan; Jeffery L Twiss; John D Houlé
Journal:  Exp Neurol       Date:  2015-09-12       Impact factor: 5.330

9.  Phenotypic assays to identify agents that induce reactive gliosis: a counter-screen to prioritize compounds for preclinical animal studies.

Authors:  Samuel R Beckerman; Joaquin E Jimenez; Yan Shi; Hassan Al-Ali; John L Bixby; Vance P Lemmon
Journal:  Assay Drug Dev Technol       Date:  2015-07-31       Impact factor: 1.738

10.  Blocking of BDNF-TrkB signaling inhibits the promotion effect of neurological function recovery after treadmill training in rats with spinal cord injury.

Authors:  Xiangzhe Li; Qinfeng Wu; Caizhong Xie; Can Wang; Qinghua Wang; Chuanming Dong; Lu Fang; Jie Ding; Tong Wang
Journal:  Spinal Cord       Date:  2018-07-12       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.